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 Introduction 
 The formation of blood vessel networks is essential to 
providing oxygen and nutrients to virtually all organs 
and tissues in the organism. Once a few nascent vessels 
are formed via a process called vasculogenesis, the fur-
ther expansion of vessel networks in development pro-
ceeds via a combination of proliferation and migration 
called sprouting angiogenesis [Risau, 1997]. Angiogene-
sis is also essential to pathological blood vessel formation 
that is associated with diseases as diverse as cancer and 
diabetes [Aiello, 2008; Heath and Bicknell, 2009; Fioretto 
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 Abstract 
 Tissue and organ viability depends on the proper systemic 
distribution of cells, nutrients, and oxygen through blood 
vessel networks. These networks arise in part via angiogenic 
sprouting. Vessel sprouting involves the precise coordina-
tion of several endothelial cell processes including cell-cell 
communication, cell migration, and proliferation. In this re-
view, we discuss zebrafish and mammalian models of blood 
vessel sprouting and the quantification methods used to as-
sess vessel sprouting and network formation in these mod-
els. We also review the mechanisms involved in angiogenic 
sprouting, and we propose that the process consists of dis-
tinct stages. Sprout initiation involves endothelial cell in-
teractions with neighboring cells and the environment to 
establish a specialized tip cell responsible for leading the 
emerging sprout. Furthermore, local sprout guidance cues 
that spatially regulate this outward migration are discussed. 
We also examine subsequent events, such as sprout fusion 
and lumenization, that lead to maturation of a nascent 
sprout into a patent blood vessel. 
 Copyright © 2011 S. Karger AG, Basel 
 Published online: October 12, 2011 
 Dr. Victoria L. Bautch 
 Department of Biology, CB#3280 
 The University of North Carolina at Chapel Hill 
 Chapel Hill, NC 27599 (USA) 
 Tel. +1 919 966 6797, E-Mail bautch   @   med.unc.edu 
 © 2011 S. Karger AG, Basel
 
 Accessible online at:
www.karger.com/cto 
Abbreviations used in this paper
BMP bone morphogenic protein
dpf days postfertilization
ECM extracellular matrix
eGFP enhanced green fluorescent protein
ES embryonic stem
FGF fibroblast growth factor
HUVEC human umbilical vein endothelial cells
ISAs intersegmental arteries
LIF leukemia inhibitory factor
NICD Notch intracellular domain
PDGF platelet-derived growth factor
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et al., 2010]. The last 10 years of research have produced 
elegant models of sprouting angiogenesis as better exper-
imental tools and model systems have become available. 
Specifically, the ability to selectively delete genes in devel-
oping mouse vessels using vascular-specific Cre driver 
mouse lines and mice with loxP recombination sites in 
genes has allowed us to assess the specific function of 
genes in mammalian vascular development. The ability 
to regulate excision temporally via inducible Cre driver 
lines has also allowed researchers to focus on genetic re-
quirements at the developmental time that requires 
sprouting angiogenesis. These advances have been com-
plimented by extensive improvements in our ability to 
assess vessel sprouting – from confocal microscopy with 
numerous vessel markers to the development of live im-
aging techniques in several models, including the genet-
ically tractable zebrafish. This combination of precise 
 genetic tools with novel technology to query cell-based 
behaviors has proven powerful in advancing our under-
standing of how blood vessel sprouting is regulated. 
 Briefly, sprouting angiogenesis is comprised of several 
distinct steps, and we believe that the following classifica-
tion reflects different temporal and/or regulatory nodes 
( fig. 1 ). First, an endothelial cell within a nascent vessel 
initiates sprouting by responding to chemotactic cues 
and extending filopodia ( fig. 1 , stage I). It is not clear how 
the ‘tip’ cell is initially specified, although subsequently 
there is a competition for the tip cell position, with cells 
experiencing elevated VEGF signaling at an advantage 
for tip cell position over neighbors with less VEGF signal-
ing [Jakobsson et al., 2010]. Once the tip cell begins to 
move out, local guidance cues help ensure that the newly 
emerging sprout moves away from the parent vessel in-
stead of rejoining it, and the soluble form of the VEGF 
receptor VEGFR-1 (Flt-1) is implicated in this guidance 
[Chappell et al., 2009] ( fig. 1 , stage II). As the sprout con-
tinues to extend, several changes occur ( fig. 1 , stage III). 
First, the sprout leaves the environment of local guidance 
cues and becomes capable of responding to cues from the 
microenvironment and/or other vessels or sprouts. It also 
now has cells behind the leading tip cell, called ‘stalk 
cells’, that are more likely to undergo cell division than 
the tip cell. Finally, as the sprout extends, lumens begin 
to form by poorly understood processes ( fig. 1 , stage IV). 
The final stages of sprouting angiogenesis involve cell-
cell interactions that lead to fusion of the tip cell with an-
other sprout tip cell or a vessel and the formation of a 
patent lumen that provides a new conduit ( fig. 1 , stage V). 
The outcomes of sprouting angiogenesis are an expanded 
vessel network that delivers oxygen and nutrients to tis-
sues, and a plexus that can be subsequently remodeled by 
physiological cues such as blood flow. 
 In this brief review we focus on recent advances in 










 Fig. 1. Stages of blood vessel sprouting. We propose that blood 
vessel sprouting occurs in distinct stages characterized by spe-
cific cellular processes and specific (although partially overlap-
ping) molecular requirements. Stage I is tip cell specification and 
sprout initiation that occurs by poorly understood processes; 
stage II is sprout elongation and local guidance that features 
VEGF/Flt-1 near-field interactions; stage III is sprout elongation 
in response to extrinsic cues; stage IV is lumen formation, and 
stage V is sprout fusion and completion of lumenization to pro-
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discuss methods for quantification of vessel sprouting 
that have been developed by our group and others. The 
ability to measure precise quantitative parameters has 
allowed researchers to provide statistical significance to 
abnormalities as well as reveal more subtle perturba-
tions of sprouting angiogenesis. We refer the reader to 
numerous recent reviews that cover aspects of angiogen-
esis in more detail [Roca and Adams, 2007; Iruela-Aris-
pe and Davis, 2009; Phng and Gerhardt, 2009; Chappell 
et al., 2011]. 
 Blood Vessel Sprouting in Zebrafish  
 Zebrafish are transparent as embryos and undergo 
rapid development, which provides a unique system for 
imaging angiogenesis in vivo [Lawson and Weinstein, 
2002]. Zebrafish are highly conducive to the use of anti-
sense oligomers known as morpholinos that can block 
gene expression and create gene ‘knockout’ scenarios 
[Eisen and Smith, 2008]. In addition, genetic and molecu-
lar tools available in zebrafish are continuing to expand. 
 Regions of Vessel Sprouting  
 Blood begins to circulate at 24 h postfertilization in 
zebrafish. The primitive circulatory loop in zebrafish is 
composed of the dorsal aorta and cardinal vein. The in-
tersegmental arteries (ISAs) initially sprout from the 
dorsal aorta between 1 day postfertilization (dpf) and 2 
dpf and form chevron-shaped vessels [Isogai et al., 2003]. 
The quick development and stereotypical morphology of 
the ISAs makes them useful for studying angiogenesis. 
While the ISAs have received the most attention for 
studying zebrafish angiogenesis, other sites are the focus 
of recent studies, including vascularization of the gut 
and fins [Hu et al., 2006; Ma et al., 2007], formation of 
the aortic arches [Nicoli et al., 2010], and sprouting from 
the posterior caudal vein [Hermans et al., 2010; Wiley et 
al., 2011]. 
 The ISAs form between somites via migratory move-
ments restricted by the somites [Childs et al., 2002]. The 
somites provide important chemotactic cues such as 
VEGF [Lawson et al., 2002], and they also act as a physi-
cal barrier by which these stereotypical blood vessels are 
guided. However, many vascular beds form without 
physical barriers, and consequently they rely more heav-
ily on the free movements of endothelial sprouts to form 
proper connections and expand. An example of ‘free 
forming’ angiogenesis in the zebrafish is the develop-
ment of the caudal vein plexus in the sparsely populated 
regions near the tail. The formation of this plexus in-
volves dynamic endothelial cell movements and intercel-
lular communication. Interestingly, the stereotypical 
ISAs sprout in response to VEGF signaling, whereas the 
‘free forming’ caudal vein plexus is uniquely dependent 
on bone morphogenetic protein (BMP) signaling for 
sprouting angiogenesis [Wiley et al., 2011]. Thus, BMP 
stimulates venous sprouting even with disruption of 
VEGF signaling, suggesting that the two pathways regu-
late arterial and venous angiogenic sprouting indepen-
dently. 
 Quantification Methods in Zebrafish  
 The expanded use of the zebrafish to study sprouting 
angiogenesis has occurred largely through the develop-
ment of vascular-specific reporters and advances in im-
aging techniques. The  fli1 and  flk1 genes are used to drive 
expression of enhanced green fluorescent protein (eGFP) 
in the developing zebrafish vasculature [Cha and Wein-
stein, 2007]. Multiphoton imaging of these reporter fish 
facilitates long-term, dynamic imaging of blood vessels 
during their formation [Kamei et al., 2010], which has led 
to many important insights into vessel sprouting. In ad-
dition, systems for screening pro- and antiangiogenic 
agents have been developed using these reporter lines 
[Tran et al., 2007]. 
 There are numerous ways to quantify angiogenic 
events and to score defects in zebrafish blood vessel for-
mation. The penetrance of an angiogenic defect can be 
represented by simply determining the percentage of em-
bryos that contain the defect. However, angiogenic per-
turbations are often complex and diverse. Therefore, it is 
often more informative to sort zebrafish into different 
classes that reflect the severity of the angiogenic disrup-
tion. The percentage of embryos in each class is then used 
to represent the diversity of angiogenic defects. An alter-
native way to represent the severity of a phenotype is to 
determine the percentage of segments per embryo that 
contain a specified disturbance, where each segment is 
defined as the area on the anterior-posterior axis between 
two adjacent somite boundaries. For example, normal 
ISA development would result in 1 sprout/segment, while 
excess sprouting from the dorsal aorta or ISAs would re-
sult in  1 1 sprout/segment. One can also use the segment 
boundaries to quantify ectopic vessels, an example being 
quantification of the ectopic sprouting from the caudal 
vein in embryos overexpressing Bmp2 [Wiley et al., 2011]. 
It is predicted that other quantification protocols will be 
developed as distinct vascular beds within the developing 
zebrafish are studied in the future. 
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 Blood Vessel Sprouting in Mammalian Systems  
 A range of mammalian-based experimental models 
have been developed to observe blood vessel sprouting 
( fig. 2 ). An ideal model would facilitate observation of in-
dividual endothelial cells during the sprouting process, 
and each cell would exhibit their behaviors in the appro-
priate physiological or pathological context. Here we de-
scribe several in vitro, in situ, and in vivo models com-
monly used to investigate angiogenic sprouting in mam-
malian-based systems. These three groups represent a 
continuum of both biological complexity and ease of ma-
nipulation. In vitro platforms are the least complex in 
terms of cellular inputs and environmental factors and are 
therefore most amenable to experimental intervention. 
Although slightly more difficult to manipulate, in situ 
models offer an increase in complexity as the cellular and 
environmental components of the sprouting environment 
more closely resemble that of vessels sprouting within an 
animal. In vivo approaches capture blood vessels sprout-
ing in their most physiologically relevant context, but 
these models are also the most challenging to manipulate 
and require innovative experimental techniques. We de-
scribe the strengths and limitations of each model in pro-
viding insight into sprouting and vessel branching. Im-
portant caveats of each model system to be considered 
when interpreting observations are highlighted as results 
from a particular model or tissue site are often context 
dependent and not necessarily applicable to all situations. 
 Mammalian Models of Vessel Sprouting  
 This compilation of models is by no means compre-
hensive, but it provides examples of different categories 
of models and how they are used. 
 Fig. 2. Mammalian models of blood vessel sprouting. Summary 
of strengths and limitations for each model discussed, as well as a 
general schematic of each model and reference to a publication 
with detailed methods for utilizing the model, although multiple 
publications describe and use most models. Green cells represent 
endothelial cells, and tan cells represent other cell types present 
in each model. The gray sphere in the fibrin bead assay category 
represents the microcarrier bead to which the endothelial cells at-
tach, and the gray area in the rat mesentery assay represents the 
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 In vitro Models of Vessel Sprouting  
 In vitro blood vessel sprouting assays recapitulate 
many important aspects of sprout formation. These sys-
tems are limited in modeling the full range of in vivo in-
fluences on endothelial cell sprouting, including blood 
flow and circulating factors. Nevertheless, this reduced 
complexity can be beneficial for understanding this high-
ly dynamic process as sprouting cells and their neighbors 
can be readily visualized and easily manipulated. The fi-
brin bead assay is an in vitro model in which microcar-
rier beads are coated with endothelial cells such as human 
umbilical vein endothelial cells (HUVEC) and embedded 
in a fibrin matrix topped by fibroblasts that provide pro-
angiogenic cues [Nehls and Drenckhahn, 1995; Sainson 
et al., 2005; Nakatsu and Hughes, 2008]. Approximately 
2–4 days after embedding, endothelial cells sprout into 
the fibrin matrix, and new branches extend from these 
initial vessel-like structures at 3–5 days. A similar ap-
proach has been developed using 3-dimensional collagen 
matrix and endothelial cells from a variety of sources 
[Goto et al., 1993; Kamei et al., 2006; Koh et al., 2008; Bay-
less et al., 2009]. In this assay, endothelial cells are ini-
tially configured as a monolayer on top of the collagen, 
and within a day sprouts extend and branch down into 
the matrix in response to proangiogenic factors. 
 In these models, cells can be manipulated genetically 
and pharmacologically with relative ease, and live imag-
ing by video microscopy can be complemented with 
fixed-image analysis to resolve individual cells and their 
behaviors [Nakatsu and Hughes, 2008; Bayless et al., 
2009]. Furthermore, the sprouting environment can be 
altered by manipulating extracellular matrix (ECM) 
components [Bayless and Davis, 2003] or by selectively 
adding other cell types or molecules and determining 
their effects on vessel formation [Nehls et al., 1994; Diet-
rich and Lelkes, 2006; Liu et al., 2008; Stratman et al., 
2009]. Recent studies have extended these assays further 
by including fluid movement to model effects of blood 
flow [Kang et al., 2008] and interstitial fluid flow on en-
dothelial sprouting [Vickerman et al., 2008; Hernandez 
Vera et al., 2009]. 
 In addition to the strengths discussed above, these in 
vitro systems also have certain limitations to be consid-
ered when interpreting observations. Important physio-
logical features, such as mechanical inputs from tissue 
deformation/expansion and blood flow, are lacking in 
these models. Furthermore, given that the endothelial 
cells used often come from a generic source and not nec-
essarily from a tissue undergoing angiogenesis, essential 
context-dependent cues that set up and maintain endo-
thelial heterogeneity may be altered in, or even absent 
from, these assays. Finally, the geometry of the collagen 
sprouting model (i.e. the downward extension of sprouts) 
presents an additional limitation because it is not condu-
cive to image analysis. Overall, in vitro models of endo-
thelial sprouting have provided, and will continue to 
yield, many important insights into angiogenic sprouting 
and vessel branch formation, and coupling these observa-
tions with other experimental approaches will certainly 
elucidate essential mechanisms involved in this complex 
process. 
 In situ Models of Vessel Sprouting  
 Several in situ models have been developed that retain 
key features of in vivo vascular sprouting while offering 
relative ease of experimental manipulation and accessi-
bility for live imaging. The endogenous genetic programs 
underlying vessel formation and morphogenesis are still 
present, in addition to the complex interactions between 
various cell types, but the macroenvironment can still be 
tightly controlled and manipulated for experimental pur-
poses. 
 After removal of leukemia inhibitory factor (LIF) from 
the media, mouse embryonic stem (ES) cells undergo a 
programmed differentiation in standard culture condi-
tions and form multiple cell types, including vascular en-
dothelial cells that form primitive lumenized vessels 
[Doetschman et al., 1985; Risau et al., 1988; Wang et al., 
1992; Jakobsson et al., 2007b; Zeng and Bautch, 2009]. 
Primitive vessels form via vasculogenesis and subsequent 
sprouting angiogenesis in a context similar to that of the 
developing embryo and yolk sac, particularly in terms of 
other cell types that provide important inductive and de-
velopmental cues, such as the underlying endoderm. This 
model is especially amenable to high-resolution live im-
aging [Kearney et al., 2004; Chappell et al., 2009] since 
the 3-dimensional vessels form in a relatively limited por-
tion of the z-axis, somewhat like a pancake. 
 Alternatively, partially differentiated ES cells are cul-
tured in a 3-dimensional collagen matrix, and developing 
vessels are induced to sprout into the surrounding colla-
gen through the addition of exogenous growth factors 
[Jakobsson et al., 2006; Li et al., 2008; Chappell et al., 
2009; Jakobsson et al., 2010]. In this collagen-embedded 
ES cell differentiation model, different aspects of angio-
genic sprouting can be investigated by analysis of both 
primary sprouts and the secondary branches that emerge 
from these initial vessels. These vessels also become lu-
menized [Jakobsson et al., 2007a, b]. Since the vessels 
sprout away from the other cell types, there is a distinct 
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sprouting direction in this model. This model is also 
amenable to live imaging although currently at a lower 
resolution than is possible with vessels that form over an 
endoderm layer (see above). 
 The mouse allantois is an embryonic tissue that can 
be excised and cultured under conditions in which an-
giogenic expansion occurs [Drake and Fleming, 2000; 
Downs et al., 2001; Crosby et al., 2005]. This extraembry-
onic tissue is composed largely of mesoderm and gives 
rise to the chorioallantoic placenta. Primitive vessels 
form in the allantois between embryonic days E6.5 and 
E7.5 through vasculogenesis. Extraction is usually at 
E7.5, and subsequent culture for 24–48 h supports angio-
genic expansion [Argraves et al., 2002; Perryn et al., 
2008]. Since the initial stages of blood vessel formation 
occur in vivo in the context of blood flow, the plexus has 
normal mechanical cues prior to culture. The allantois 
model is also useful for analysis of mutations that are 
embryonic lethal post-E7.5, for analysis of complex ge-
netic crosses, or for experimental conditions that pro-
hibit in vivo analysis (i.e. reporter loci in a mutant back-
ground or during severely disrupted conditions). For ex-
ample, Winderlich et al. [2009] utilized the GFP reporter 
driven by the VE-cadherin promoter to dynamically vi-
sualize allantois vessel formation during pharmacologi-
cal intervention. 
 An approach similar to the allantois culture model is 
the mouse embryo culture system, in which the whole 
embryo including the yolk sac is isolated between 7.5 and 
12.5 dpc and cultured for 24 h or more [Megason and 
Fraser, 2003; Garcia et al., 2011]. Using this platform, 
sprouting events within the developing yolk sac plexus 
can be observed, and the tools for observing these blood 
vessels are expanding [Larina et al., 2009]. This approach 
may also serve as a means to assess embryonic lethal mu-
tations. 
 One feature of these models is that blood vessel sprout-
ing can be observed with real-time and fixed imaging, as 
done with in vitro models, but in the context of other 
physiologically relevant cell types and genetic programs 
[Kearney et al., 2004; Jakobsson et al., 2006; Chappell et 
al., 2009]. For example, the current paradigm for endo-
thelial proliferation in sprouting angiogenesis is that the 
tip cell rarely divides, whereas stalk cells undergo divi-
sions to lengthen a vessel [Gerhardt et al., 2003]. Dynam-
ic imaging of ES cell-derived vessel sprouts, however, has 
revealed that tip cells sometimes retract and subsequent-
ly divide, highlighting the importance of coupling fixed-
image analysis with time-lapse observations [Chappell 
and Bautch, unpubl. res.]. Furthermore, the additional 
cell populations present in these models provide impor-
tant molecular cues [Ng et al., 2004], as well as essential 
mechanical cues [Perryn et al., 2008], that contribute to 
a more faithful reconstruction of the in vivo environ-
ment. 
 The limitations of these models of vessel sprouting 
should also be considered. A particular model may not 
include all relevant cell types in a given sprouting context, 
which may limit broader interpretation of the results. For 
example, macrophages may contribute to guiding the
fusion between two sprouting endothelial cells [Fantin
et al., 2010], and these macrophages may not be as abun-
dant in the in situ models as they are in vivo. These mod-
els also lack mechanical inputs associated with blood 
flow. As with in vitro models, the limitations of fully re-
capitulating a physiological sprouting environment ne-
cessitate corroborating in situ observations with in vivo 
approaches. 
 In vivo Models of Vessel Sprouting  
 In vivo models of endothelial sprouting offer insight 
into underlying mechanisms that occur in a physiological 
context. These systems include the mechanical inputs 
from blood flow, interstitial fluid movement, and tissue 
deformation in addition to the effects from a wider range 
of cell types. Moreover, the ECM composition and physi-
cal constraints imposed by the surrounding tissue may 
further distinguish different in vivo sprouting environ-
ments. 
 Blood vessel sprouting in vivo has been investigated 
using several mouse models. The developing mouse reti-
nal vasculature has recently gained significant attention. 
At birth, blood vessels emerge through the optic disc at 
the base of the retina. Over 8 days (P0 to P8), these vessels 
expand radially toward the outer edge of the retina, pre-
dominantly through angiogenic sprouting [Stalmans et 
al., 2002; Fruttiger, 2007; Pitulescu et al., 2010]. Numer-
ous endothelial tip cells emerge from the front of this ex-
panding vascular network, and the filopodia from these 
sprouting cells are prominent and useful indicators of en-
dothelial cell behavior [Gerhardt et al., 2003; Suchting et 
al., 2007; Chappell et al., 2009]. Strengths of the retinal 
vessel model are: (1) the network does not expand exten-
sively in the z-axis so it is ideal for confocal image analy-
sis; (2) the vessels mature and remodel from the optic disc 
outward, allowing for simultaneous analysis of different 
stages of remodeling and clear demarcation of arterial vs. 
venous beds; (3) the eye is accessible for intraocular injec-
tion of drugs, antibodies, and viruses, and (4) the eye is 
dispensable for life so it can be dramatically locally per-
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turbed without lethality. Limitations are: (1) the vessels 
migrate outward over a network of astrocytes, so pertur-
bations to this underlying astrocyte network can perturb 
vessel patterning, and (2) retinal vessels do not survive for 
significant periods of time ex vivo [Sawamiphak et al., 
2010a, b], making live imaging difficult [C. Lee and VL 
Bautch, unpubl. res.]. Vessel sprouting and filopodial ex-
tensions from tip cells have been observed in mouse em-
bryonic tissues as well, including the hindbrain [Ruhr-
berg et al., 2002; Gerhardt et al., 2004; Suchting et al., 
2007; Fantin et al., 2010] and skin [Benedito et al., 2009] 
[Heinz and Bautch, unpubl. res.]. These sites are useful if 
embryonic lethality is an issue, and they provide an alter-
native to the retina; however, they are more difficult to 
access and image than the retina. 
 Rat models, e.g. the rat mesentery model, have also 
been developed for observing in vivo vascular sprouting. 
Following an inflammatory insult or exposure to proan-
giogenic factors, extensive angiogenic sprouting occurs 
across the mesenteric connective tissue [Anderson et al., 
2004; Benest et al., 2008]. This thin tissue is amenable to 
confocal microscopy, comparable to the retina tissue, but 
the limited genetic tools available in the rat have prevent-
ed wider usage. 
 Angiogenic sprouting is an important aspect in a 
number of pathological conditions. Tumors secrete large 
amounts of angiogenic factors, including VEGF-A, to 
stimulate the in-growth and expansion of blood vessels, 
and thus many solid tumor models contain observable 
sprouting events. These sprouts experience aberrant 
VEGF and Notch-Delta signaling [Patel et al., 2005; Ridg-
way et al., 2006], which results in morphological defects 
such as perturbed deposition of basement membrane 
around vessel sprouts [Baluk et al., 2003]. Vessel sprout 
density and morphology observations complement tu-
mor size and vascularity metrics to assess the effects of 
drug and gene treatments on vessel formation [Morikawa 
et al., 2002; Baluk et al., 2003; Ocak et al., 2007; Hashi-
zume et al., 2010]. However, the 3-dimensional nature of 
most tumors presents a challenge for high-resolution im-
aging of tumor vessels. 
 Quantification Methods in Mammalian Systems  
 Selecting the appropriate metrics for a given model 
or analysis is essential to determine which aspects of 
sprouting are perturbed by a particular experimental 
manipulation. Rigorous quantification can help distin-
guish natural heterogeneity in morphology and behav-
ior from differences that result from a specific genetic or 
pharmacological intervention. Assessment of vessel and 
sprout morphology often involves both manual and au-
tomated approaches as image quality can hamper com-
plete automation of most measurements; however, im-
age analysis tools such as Metamorph, ImageJ, and VES-
GEN 2D provide resources for incorporating automated 
strategies [Vickerman et al., 2009]. In the following sec-
tion, we discuss several quantification methods that 
have been applied to mammalian models of blood vessel 
sprouting. 
 The vessels that develop in the in vitro bead assays 
rarely interconnect unless two beads are in close proxim-
ity, and thus a highly branched plexus does not often 
form. Instead, endothelial cells primarily sprout from the 
beads and from initial primitive vessels extending from 
the beads. The frequency of sprouting in these contexts 
can be measured to assess how experimental manipula-
tions affect sprout initiation. Sprout thickness/diameter 
and sprout length quantification can provide further in-
sight into how cells are allocated for vessel growth – i.e. 
for sprouting, vessel elongation, or radial expansion. Lu-
men frequency and size can also be quantified. Similar 
parameters can be applied to vessel sprouting from em-
bryoid bodies imbedded in collagen as secondary sprouts 
also emerge from primary vessel extensions in this mod-
el [Chappell et al., 2009; Jakobsson et al., 2010]. Both 
models can be assessed for the spatial orientation of sec-
ondary sprouts relative to the primary vessel (e.g. sprout 
angle) and to other sprouts (e.g. distance between sprouts) 
to determine if vessel-intrinsic mechanisms are affected 
[Chappell et al., 2009]. 
 The mechanisms underlying sprout initiation and 
sprout guidance share common features, but they also 
have distinct requirements such as the absolute versus 
relative VEGF-A levels [Gerhardt et al., 2003] and the 
proper spatial distribution of certain molecules such as 
Flt-1 [Chappell et al., 2009]. Overall vessel branching 
morphology results from the proper regulation of many 
cellular behaviors. Thus, quantifying vessel branching 
may reveal if one or more of these behaviors of vessel 
sprouting is defective and suggest additional measure-
ments to complement initial observations. 
 The branching density of vessels derived from ES cells 
can be determined by measuring vessel branch points 
normalized to vessel length. The spacing between sprouts/
branches, the sprout angle relative to the parent vessel, 
and the number and angle of filopodia relative to the 
sprout axis are quantified to assess the degree to which a 
sprout is guided by local cues and is able to extend effi-
ciently away from the parent vessel [Chappell et al., 2009]. 
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 Several in vitro and in situ sprouting assays are ob-
servable via live imaging. Therefore, the element of time 
can be included in the overall assessment of vessel sprout-
ing. The rate and frequency of sprout formation, the 
speed of sprout migration, or changes in sprout direc-
tionality over time are measurable, and these measure-
ments can contribute to an enhanced description of how 
sprouting is affected by experimental perturbations 
[Roberts et al., 2004; Chappell et al., 2009; Jakobsson et 
al., 2010]. 
 In the developing retinal vasculature, assessing vessel 
density via branch point quantification is essential for 
determining differences between experimental groups 
as there is heterogeneity in vessel density even within one 
retina [Pitulescu et al., 2010]. Other metrics that quan-
tify vessel perturbations include enumeration of tip cells 
extending from the vascular front, and filopodia number 
per tip cell and per vessel length [Hellstrom et al., 2007]. 
The angle and length of filopodia relative to the tip cell/
sprout and distance between sprouts can be measured to 
indicate changes in the spatial information guiding tip 
cell migration [Suchting et al., 2007; Chappell et al., 
2009]. 
 Mechanisms of Blood Vessel Sprouting  
 Blood vessels sprout in response to exogenous factors 
secreted by tissues requiring an increased vascular sup-
ply. The heterogeneous response of endothelial cells to 
these stimuli results in the organization and specializa-
tion of cells for particular functions. An endothelial ‘tip’ 
cell, for example, is selected to sprout outward from the 
parent vessel and lead the extending sprout to a target 
vessel or sprout for fusion and subsequent lumen forma-
tion. The following sections describe processes involved 
in blood vessel sprouting and their contribution to the 
expansion and patterning of the blood vasculature. 
 Sprout Initiation 
 Tip cell specification is important in the expansion of 
various tubular networks ( fig. 1 , stage I). Although the 
initial specification of an endothelial tip cell from a group 
of ‘naïve’ cells in a vessel is poorly understood, it may oc-
cur via competition. During  Drosophila trachea forma-
tion, epithelial cells compete for the lead position of ex-
tending tracheal branches [Ghabrial and Krasnow, 2006]. 
A tip cell becomes specialized to lead the nascent branch 
by increased fibroblast growth factor (FGF) receptor 
(Breathless) activation and by lateral inhibition of trailing 
cells through Notch signaling. The tracheal tip cell uses 
numerous filopodia to sense environmental cues such as 
FGF (Branchless) and direct sprout extension [Ribeiro et 
al., 2002]. The growth cones of axons also interpret envi-
ronmental spatial cues using filopodia [Kater and Rehder, 
1995]. 
 Once a vessel sprout forms, endothelial cells appear to 
compete similarly to take the lead position based on re-
sponsiveness to VEGF-A, a potent regulator of angiogen-
ic sprouting [Jakobsson et al., 2010]. The VEGF tyrosine 
kinase receptor Flk-1 (VEGFR2) positively regulates en-
dothelial migration, while the VEGF receptor Flt-1 (VEG-
FR1) acts primarily as a ligand sink [Kendall and Thom-
as, 1993]. Thus cells with high Flk-1 or low Flt-1 levels 
assume the tip cell position more frequently [Jakobsson 
et al., 2010], and the levels of these receptors are also reg-
ulated in part by Notch signaling ( fig. 3 ) [Henderson et 
al., 2001; Holderfield et al., 2006; Suchting et al., 2007; 
Harrington et al., 2008; Phng et al., 2009; Funahashi et 
al., 2010; Jakobsson et al., 2010]. 
 In addition to regulating VEGF receptor levels, the 
Notch pathway also modulates tip/stalk cell dynamics 
through lateral inhibition. The Notch signaling pathway 
involves 4 Notch receptors, Notch1–4, and the 5 ligands: 
Delta-like 1 (Dll1), Dll3, Dll4, and Jagged-1 (Jag-1) and 
Jag-2. Because these receptors and ligands are transmem-
brane proteins, signaling requires cells to be in close 
proximity. The Notch intracellular domain (NICD) is re-
leased from the cell membrane through proteolytic cleav-
age following the binding of a Notch receptor by a ligand 
on an adjacent cell. Downstream transcription targets are 
activated after this NICD translocates into the nucleus 
and forms an activating complex. When an endothelial 
cell expresses higher levels of Notch ligands than neigh-
boring cells, adjacent endothelial cells experience in-
creased Notch signaling which increases Flt-1 expression 
and prevents adoption of the tip cell phenotype. 
 Recent observations suggest that lateral inhibition fa-
cilitates tip cell specification at the outset of sprouting 
angiogenesis because VEGF-A induces Dll4 expression
in endothelial cells that will adopt a tip cell phenotype 
( fig. 3 ) [Liu et al., 2003; Lobov et al., 2007; Suchting et al., 
2007]. Additionally, endothelial cells deficient in Notch1 
activity preferentially assume the tip cell position in mice 
[Hellstrom et al., 2007], while zebrafish endothelial cells 
overexpressing the NICD rarely have tip cell characteris-
tics [Siekmann and Lawson, 2007]. Inhibiting Notch sig-
naling by blocking the cleavage of NICD (i.e. via treat-
ment with   -secretase inhibitors such as DAPT) induces 
excessive tip cell specification in zebrafish and in mice 
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[Hellstrom et al., 2007; Leslie et al., 2007]. Genetic disrup-
tions of Dll4 in zebrafish and mice phenocopy defects 
seen in developing blood vessels treated with   -secretase 
inhibitors. Morpholinos against the Notch pathway com-
ponents Dll4 [Siekmann and Lawson, 2007], notch1b 
[Leslie et al., 2007], and recombining binding protein 
suppressor of hairless (Rbpja) [Siekmann and Lawson, 
2007] cause hyperbranching in zebrafish. Interestingly, 
genetic manipulation of endothelial Notch1 expression in 
mice does not always yield a sprouting phenotype [Lim-
bourg et al., 2005; Krebs et al., 2010], suggesting that 
Notch regulation of sprouting is context dependent. Nev-
ertheless, recent data supports a role for Notch signaling 
in regulating vessel sprouting by inhibiting tip cell speci-
fication. 
 Several angiogenic factors are also transcriptionally 
regulated by the Notch pathway [Siekmann et al., 2008], 
which likely contributes to tip cell specification or main-
tenance ( fig. 3 ). For instance, Notch negatively regulates 
expression of the VEGF-A coreceptor Neuropilin-1 
(Nrp-1) [Williams et al., 2006]. Tip cells also express high 
levels of Flt-4 (VEGFR3), and Notch inhibition upregu-
lates Flt-4 expression and tip cell formation, which can 
be partially rescued with Flt-4 neutralizing antibodies 
[Siekmann and Lawson, 2007; Tammela et al., 2008]. In-
terestingly, increased Notch signaling via introduction 
of constitutively active constructs also upregulates Flt-4 
expression and perturbs vessel formation [Shawber et al., 
2007]. These apparent discrepancies may depend on tis-
sue-specific requirements for the VEGF and Notch path-
ways. As stated briefly above, Flk-1 is negatively regu-
lated by Notch signaling [Henderson et al., 2001; Hold-
erfield et al., 2006], while Flt-1 is positively regulated 
( fig. 3 ) [Harrington et al., 2008; Funahashi et al., 2010]. 
Since Flt-1 modulates Flk-1 activation by VEGF [Roberts 
et al., 2004; Kappas et al., 2008], increased expression of 
Flt-1 by stalk cells dampens VEGF responsiveness and 
limits their capacity to sprout [Chappell et al., 2009; Ja-
kobsson et al., 2010]. Thus, tip cell selection appears to 
be modulated through Notch regulation of multiple an-
giogenic factors. 
 Live imaging of angiogenic sprouts suggests that Notch-
mediated lateral inhibition and in turn the occupancy of 
the lead position are highly dynamic [Jakobsson et al., 
2010]. This can hamper clear identification of tip cells, and 
expression of relevant markers shows small differences 
relative to neighboring cells in fixed images. Some mark-
ers expressed by tip cells include apelin, CXCR4, Dll4, Flk-
1, Flt-4, platelet-derived growth factor (PDGF)-b, and
UNC5b [Gerhardt et al., 2003; Claxton and Fruttiger, 
2004; Lu et al., 2004; Hellstrom et al., 2007; Siekmann and 
Lawson, 2007; del Toro et al., 2010; Strasser et al., 2010]. 
Thus, both expression patterns and morphological fea-
tures such as lack of a lumen and extension of numerous 
long filopodia are used to distinguish tip cells in fixed im-
ages. Overall, tip cell specification is essential for sprout 
initiation and vascular branch formation. 
 Sprout Guidance  
 The role for VEGF-A as a guidance cue for endothe-
lial sprouts has been well established [Gerhardt, 2008]. 
The three predominant VEGF-A isoforms, generated via 
alternative splicing, vary in their binding affinities for the 
ECM due to the presence or absence of heparin-binding 
domains [Tischer et al., 1991]. Proper spatial distribution 
of VEGF-A depends on variable ECM affinity, and ge-
netic perturbation of VEGF-A isoforms disrupts vessel 
patterning [Ruhrberg et al., 2002; Stalmans et al., 2002]. 
We recently identified a mechanism by which soluble Flt-
1 (sFlt1) expressed by endothelial cells adjacent to an 
emerging sprout provide additional refinement of near-
 Fig. 3. Molecular regulation of blood vessel sprouting. The VEGF-
A ligand (green diamonds) binds the Flk-1 receptor (orange Y) on 
the tip cell, increasing Dll4 expression. The Dll4 ligand engages 
the Notch receptor on the neighboring lateral base cells and pro-
motes cleavage of the NICD. Translocation of the NICD into the 
nucleus increases expression of downstream genes including Hey 
and Hes family genes, which may then decrease Flk-1 and Nrp-1 
expression and increase expression of Flt-1 (blue Ys). 
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field VEGF-A gradients ( fig. 3 ) [Chappell et al., 2009]. In 
this way, a more directed VEGF-A gradient is created to 
guide outward sprouting ( fig. 1 , stage II), and this guid-
ance is compromised when these lateral base cells do not 
express sFlt-1. Additional reinforcement of local VEGF-A 
gradients may occur through the release of VEGF-A di-
rectly from endothelial cells [Lee et al., 2007; da Silva et 
al., 2010] or from proteolytic cleavage of the ECM [Helm 
et al., 2005; Vempati et al., 2010]. Alternatively, ECM re-
tention of VEGF-A likely guides sprouting and promotes 
branch formation [Lee et al., 2005; Chen et al., 2010]. 
Thus, endothelial sprout guidance depends on various 
mechanisms that regulate spatial VEGF-A presentation. 
 Tip cell filopodia contain Flk-1 for sensing the VEGF-
A gradients described above ( fig. 1 , stage III) [Gerhardt et 
al., 2003]. In addition, integrins on these filopodia bind 
ECM components, facilitating migration along the ma-
trix [Hynes, 2002; Anderson et al., 2004]. In certain con-
texts, vessel sprouts also interact with other cell types in 
the vicinity of sprouting, such as zebrafish intersegmen-
tal vessels and adjacent somites [Lawson and Weinstein, 
2002; Isogai et al., 2003] and mouse retinal endothelium 
and underlying astrocytes [Dorrell et al., 2002; Gerhardt 
et al., 2003]. Sprout guidance from these cell-cell interac-
tions often includes attractive-repulsive cues that have 
been adapted from the axonal guidance system [Carme-
liet and Tessier-Lavigne, 2005; Adams and Eichmann, 
2010] such as UNC5b interactions with netrin [Lu et al., 
2004] and robo4 [Koch et al., 2011], or Nrp-1 with VEGF-
A [Gerhardt et al., 2004; Jones et al., 2008]. A nascent 
spout must therefore integrate guidance information 
from soluble cues, ECM elements, and other cells for 
proper outward migration. 
 Sprout Maturation  
 A sprouting vessel transitions into a functional vascu-
lar branch by fusing with a target sprout/vessel, develop-
ing a lumen, and becoming stable and quiescent ( fig. 1 , 
stages IV and V). Recent in vivo and computational evi-
dence suggests that tip cell filopodia from approaching 
sprouts interact to initiate junction formation [Bentley et 
al., 2009]. These cells likely increase cell-cell junctions to 
maintain and reinforce their initial connection [Dorrell 
et al., 2002; Almagro et al., 2010]. Without junction rein-
forcement, cells may continue seeking another target, or 
they may ultimately retract. Embryonic macrophages 
may also facilitate sprout fusion in some contexts by 
bridging sprouts to their potential target [Fantin et al., 
2010]. Thus, tip cell filopodia interactions initiate and re-
inforce of cell-cell contacts and sprout fusion. It remains 
unknown, however, exactly how a vessel sprout deter-
mines its target for fusion. 
 For blood to begin flowing through a new vessel 
branch, a connected sprout must ultimately acquire a 
functional lumen ( fig. 1 , stage IV) [Iruela-Arispe and Da-
vis, 2009]. Recent studies indicate that the mechanisms 
involved in lumenization are context dependent. Tip cells 
in mouse retinal vessels do not have lumens in general, 
but the cell immediately behind the tip cell usually con-
tains a patent lumen [Gerhardt et al., 2003]. In the devel-
oping mouse aorta, the lumen expands through orches-
trated endothelial cell shape changes following changes 
in their polarity [Strilic et al., 2009]. Furthermore, the 
negative charge on apical surface glycoproteins generates 
electrostatic repulsion that helps force apart adjacent en-
dothelial cells, and luminal expansion is disrupted by loss 
of this negative charge [Strilic et al., 2010]. In contrast, 
fusion of intracellular and intercellular vacuoles between 
and perhaps within endothelial cells is thought to result 
in lumen formation in vessels formed in the zebrafish 
trunk and in vitro 3-dimensional collagen gels [Kamei et 
al., 2006; Blum et al., 2008]. These studies provide insight 
into the possible mechanisms governing lumen forma-
tion, yet our understanding of these processes is incom-
plete, particularly with respect to polarity cues in the en-
dothelium and their role in lumen formation. 
 Conclusions and Perspectives  
 The last 5–10 years have refined our understanding of 
how blood vessels regulate sprouting and sprout fusion to 
form new networks. Numerous in vitro, in situ, and in 
vivo models that are genetically tractable allow for precise 
determination of mechanisms and pathways involved in 
sprout regulation. Since there are strong spatial and tem-
poral components to the regulation of sprouting angio-
genesis, the advent of models that allow for high-resolu-
tion confocal image analysis and live imaging have been 
critical to advancing our knowledge. Finally, our ability 
to rigorously measure and quantify aspects of vessel 
sprouting allows for more precise determination of subtle 
but real effects from normal heterogeneity in these pro-
cesses. The advent of quantitative measures also permits 
better integration of experimental and computational 
models that are contributing to our knowledge of how 
angiogenesis is regulated [Bentley et al., 2008; Mac Gab-
hann and Popel, 2008; Merks et al., 2008; Peirce, 2008]. 
The concept that different stages of sprouting exist and 
may utilize different regulatory mechanisms should help 
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refine even further the important unresolved issues in 
sprouting angiogenesis. Expanded insight into vessel 
sprouting will in turn guide treatment of pathological 
blood vessel formation by suggesting signaling pathways 
to target for limiting vessel growth [You et al., 2011], and 
it will contribute to the optimization of bioengineering 
strategies for tissue revascularization [Leslie-Barbick et 
al., 2011].
 Acknowledgements 
 We thank members of the Bautch and Jin labs for stimulat-
ing discussions. This work was funded by NIH grants (HL43174 
and HL86465 to V.L.B.), NIH NRSA Postdoctoral Fellowship




 Adams, R.H., A. Eichmann (2010) Axon guid-
ance molecules in vascular patterning. Cold 
Spring Harb Perspect Biol  2: a001875.  
 Aiello, L.P. (2008) Targeting intraocular neovas-
cularization and edema – one drop at a time. 
N Engl J Med  359: 967–969.  
 Almagro, S., C. Durmort, A. Chervin-Petinot, S. 
Heyraud, M. Dubois, O. Lambert, C. Maille-
faud, E. Hewat, J.P. Schaal, P. Huber, D. Gu-
lino-Debrac (2010) The motor protein myo-
sin-X transports VE-cadherin along filo-
podia to allow the formation of early 
endothelial cell-cell contacts. Mol Cell Biol 
 30: 1703–1717.  
 Anderson, C.R., A.M. Ponce, R.J. Price (2004) 
Immunohistochemical identification of an 
extracellular matrix scaffold that microgu-
ides capillary sprouting in vivo. J Histochem 
Cytochem  52: 1063–1072.  
 Argraves, W.S., A.C. Larue, P.A. Fleming, C.J. 
Drake (2002) VEGF signaling is required for 
the assembly but not the maintenance of em-
bryonic blood vessels. Dev Dyn  225: 298–
304.  
 Baluk, P., S. Morikawa, A. Haskell, M. Mancuso, 
D.M. McDonald (2003) Abnormalities of 
basement membrane on blood vessels and 
endothelial sprouts in tumors. Am J Pathol 
 163: 1801–1815.  
 Bayless, K.J., G.E. Davis (2003) Sphingosine-1-
phosphate markedly induces matrix metal-
loproteinase and integrin-dependent human 
endothelial cell invasion and lumen forma-
tion in three-dimensional collagen and fi-
brin matrices. Biochem Biophys Res Com-
mun  312: 903–913.  
 Bayless, K.J., H.I. Kwak, S.C. Su (2009) Investi-
gating endothelial invasion and sprouting 
behavior in three-dimensional collagen ma-
trices. Nat Protoc  4: 1888–1898.  
 Benedito, R., C. Roca, I. Sorensen, S. Adams, A. 
Gossler, M. Fruttiger, R.H. Adams (2009) 
The notch ligands Dll4 and Jagged1 have op-
posing effects on angiogenesis. Cell  137: 
1124–1135.  
 Benest, A.V., S.J. Harper, S.Y. Herttuala, K. Ali-
talo, D.O. Bates (2008) VEGF-C induced an-
giogenesis preferentially occurs at a distance 
from lymphangiogenesis. Cardiovasc Res  78: 
315–323.  
 Bentley, K., H. Gerhardt, P.A. Bates (2008) 
Agent-based simulation of notch-mediated 
tip cell selection in angiogenic sprout initial-
isation. J Theor Biol  250: 25–36.  
 Bentley, K., G. Mariggi, H. Gerhardt, P.A. Bates 
(2009) Tipping the balance: robustness of tip 
cell selection, migration and fusion in angio-
genesis. PLoS Comput Biol  5: e1000549.  
 Blum, Y., H.G. Belting, E. Ellertsdottir, L. Her-
wig, F. Luders, M. Affolter (2008) Complex 
cell rearrangements during intersegmental 
vessel sprouting and vessel fusion in the ze-
brafish embryo. Dev Biol  316(2) : 312–322.  
 Carmeliet, P., M. Tessier-Lavigne (2005) Com-
mon mechanisms of nerve and blood vessel 
wiring. Nature  436: 193–200.  
 Cha, Y.R., B.M. Weinstein (2007) Visualization 
and experimental analysis of blood vessel 
formation using transgenic zebrafish. Birth 
Defects Res C Embryo Today  81: 286–296.  
 Chappell, J.C., S.M. Taylor, N. Ferrara, V.L. 
Bautch (2009) Local guidance of emerging 
vessel sprouts requires soluble Flt-1. Dev Cell 
 17: 377–386.  
 Chappell, J.C., D.M. Wiley, V.L. Bautch (2011) 
Regulation of blood vessel sprouting. Semin 
Cell Dev Biol, in press.  
 Chen, T.T., A. Luque, S. Lee, S.M. Anderson, T. 
Segura, M.L. Iruela-Arispe (2010) Anchor-
age of VEGF to the extracellular matrix con-
veys differential signaling responses to en-
dothelial cells. J Cell Biol  188: 595–609.  
 Childs, S., J.N. Chen, D.M. Garrity, M.C. Fish-
man (2002) Patterning of angiogenesis in the 
zebrafish embryo. Development  129: 973–
982.  
 Claxton, S., M. Fruttiger (2004) Periodic Delta-
like 4 expression in developing retinal arter-
ies. Gene Expr Patterns  5: 123–127.  
 Crosby, C.V., P.A. Fleming, W.S. Argraves, M. 
Corada, L. Zanetta, E. Dejana, C.J. Drake 
(2005) VE-cadherin is not required for the 
formation of nascent blood vessels but acts to 
prevent their disassembly. Blood  105: 2771–
2776.  
 da Silva, R.G., B. Tavora, S.D. Robinson, L.E. 
Reynolds, C. Szekeres, J. Lamar, S. Batista, V. 
Kostourou, M.A. Germain, A.R. Reynolds, 
D.T. Jones, A.R. Watson, J.L. Jones, A. Har-
ris, I.R. Hart, M.L. Iruela-Arispe, C.M. Di-
persio, J.A. Kreidberg, K.M. Hodivala-Dilke 
(2010) Endothelial alpha3beta1-integrin re-
presses pathological angiogenesis and sus-
tains endothelial-VEGF. Am J Pathol  177: 
1534–1548.  
 del Toro, R., C. Prahst, T. Mathivet, G. Siegfried, 
J.S. Kaminker, B. Larrivee, C. Breant, Du-
arte, N. Takakura, A. Fukamizu, J. Pen-
ninger, A. Eichmann (2010) Identification 
and functional analysis of endothelial tip 
cell-enriched genes. Blood  116: 4025–4033.  
 Dietrich, F., P.I. Lelkes (2006) Fine-tuning of a 
three-dimensional microcarrier-based an-
giogenesis assay for the analysis of endothe-
lial-mesenchymal cell co-cultures in fibrin 
and collagen gels. Angiogenesis  9: 111–125.  
 Doetschman, T.C., H. Eistetter, M. Katz, W. 
Schmidt, R. Kemler (1985) The in vitro de-
velopment of blastocyst-derived embryonic 
stem cell lines: formation of visceral yolk sac, 
blood islands and myocardium. J Embryol 
Exp Morphol  87: 27–45.  
 Dorrell, M.I., E. Aguilar, M. Friedlander (2002) 
Retinal vascular development is mediated by 
endothelial filopodia, a preexisting astrocyt-
ic template and specific R-cadherin adhe-
sion. Invest Ophthalmol Vis Sci  43: 3500–
3510.  
 Downs, K.M., R. Temkin, S. Gifford, J. McHugh 
(2001) Study of the murine allantois by al-
lantoic explants. Dev Biol  233: 347–364.  
 Drake, C.J., P.A. Fleming (2000) Vasculogenesis 
in the day 6.5 to 9.5 mouse embryo. Blood  95: 
1671–1679.  
 Eisen, J.S., J.C. Smith (2008) Controlling mor-
pholino experiments: don’t stop making an-
tisense. Development  135: 1735–1743.  
 Fantin, A., J.M. Vieira, G. Gestri, L. Denti, Q. 
Schwarz, S. Prykhozhij, F. Peri, S.W. Wilson, 
C. Ruhrberg (2010) Tissue macrophages act 
as cellular chaperones for vascular anasto-
mosis downstream of VEGF-mediated endo-
thelial tip cell induction. Blood  116: 829–
840.  
 Fioretto, P., P.M. Dodson, D. Ziegler, R.S. Rosen-
son (2010) Residual microvascular risk in 
diabetes: unmet needs and future directions. 
Nat Rev Endocrinol  6: 19–25.  
 Fruttiger, M. (2007) Development of the retinal 
vasculature. Angiogenesis  10: 77–88.  
 Blood Vessel Sprouting Cells Tissues Organs 2012;195:94–107 105
 Funahashi, Y., C.J. Shawber, M. Vorontchikhina, 
A. Sharma, H.H. Outtz, J. Kitajewski (2010) 
Notch regulates the angiogenic response via 
induction of VEGFR-1. J Angiogenes Res  2: 
3.  
 Garcia, M.D., R.S. Udan, A.K. Hadjantonakis, 
M.E. Dickinson (2011) Live imaging of 
mouse embryos. Cold Spring Harb Protoc 
 2011: pdb.top104.  
 Gerhardt, H. (2008) VEGF and endothelial guid-
ance in angiogenic sprouting. Organogene-
sis  4: 241–246.  
 Gerhardt, H., M. Golding, M. Fruttiger, C. Ruhr-
berg, A. Lundkvist, A. Abramsson, M. 
Jeltsch, C. Mitchell, K. Alitalo, D. Shima, C. 
Betsholtz (2003) VEGF guides angiogenic 
sprouting utilizing endothelial tip cell filo-
podia. J Cell Biol  161: 1163–1177.  
 Gerhardt, H., C. Ruhrberg, A. Abramsson, H. 
Fujisawa, D. Shima, C. Betsholtz (2004) Neu-
ropilin-1 is required for endothelial tip cell 
guidance in the developing central nervous 
system. Dev Dyn  231: 503–509.  
 Ghabrial, A.S., M.A. Krasnow (2006) Social in-
teractions among epithelial cells during tra-
cheal branching morphogenesis. Nature  441: 
746–749.  
 Goto, F., K. Goto, K. Weindel, J. Folkman (1993) 
Synergistic effects of vascular endothelial 
growth factor and basic fibroblast growth 
factor on the proliferation and cord forma-
tion of bovine capillary endothelial cells 
within collagen gels. Lab Invest  69: 508–517. 
 Harrington, L.S., R.C. Sainson, C.K. Williams, 
J.M. Taylor, W. Shi, J.L. Li, A.L. Harris (2008) 
Regulation of multiple angiogenic pathways 
by Dll4 and Notch in human umbilical vein 
endothelial cells. Microvasc Res  75: 144–154. 
 Hashizume, H., B.L. Falcon, T. Kuroda, P. Baluk, 
A. Coxon, D. Yu, J.V. Bready, J.D. Oliner, 
D.M. McDonald (2010) Complementary ac-
tions of inhibitors of angiopoietin-2 and 
VEGF on tumor angiogenesis and growth. 
Cancer Res  70: 2213–2223.  
 Heath, V.L., R. Bicknell (2009) Anticancer strat-
egies involving the vasculature. Nat Rev Clin 
Oncol  6: 395–404.  
 Hellstrom, M., L.K. Phng, J.J. Hofmann, E. Wall-
gard, L. Coultas, P. Lindblom, J. Alva, A.K. 
Nilsson, L. Karlsson, N. Gaiano, K. Yoon, J. 
Rossant, M.L. Iruela-Arispe, M. Kalen, H. 
Gerhardt, C. Betsholtz (2007) Dll4 signalling 
through Notch1 regulates formation of tip 
cells during angiogenesis. Nature  445: 776–
780.  
 Helm, C.L., M.E. Fleury, A.H. Zisch, F. Boschet-
ti, M.A. Swartz (2005) Synergy between in-
terstitial f low and VEGF directs capillary 
morphogenesis in vitro through a gradient 
amplification mechanism. Proc Natl Acad 
Sci USA  102: 15779–15784.  
 Henderson, A.M., S.J. Wang, A.C. Taylor, M. Ait-
kenhead, C.C. Hughes (2001) The basic he-
lix-loop-helix transcription factor HESR1 
regulates endothelial cell tube formation. J 
Biol Chem  276: 6169–6176.  
 Hermans, K., F. Claes, W. Vandevelde, W. Zheng, 
I. Geudens, F. Orsenigo, F. De Smet, E. Gjini, 
K. Anthonis, B. Ren, D. Kerjaschki, M. Au-
tiero, A. Ny, M. Simons, M. Dewerchin, S. 
Schulte-Merker, E. Dejana, K. Alitalo, P. 
Carmeliet (2010) Role of synectin in lym-
phatic development in zebrafish and frogs. 
Blood  116: 3356–3366.  
 Hernandez Vera, R., E. Genove, L. Alvarez, S. 
Borros, R. Kamm, D. Lauffenburger, C.E. 
Semino (2009) Interstitial f luid flow inten-
sity modulates endothelial sprouting in re-
stricted Src-activated cell clusters during 
capillary morphogenesis. Tissue Eng Part A 
 15: 175–185.  
 Holderfield, M.T., A.M. Henderson Anderson, 
H. Kokubo, M.T. Chin, R.L. Johnson, C.C. 
Hughes (2006) HESR1/CHF2 suppresses 
VEGFR2 transcription independent of bind-
ing to E-boxes. Biochem Biophys Res Com-
mun  346: 637–648.  
 Hu, G., J. Tang, B. Zhang, Y. Lin, J. Hanai, J. Gal-
loway, V. Bedell, N. Bahary, Z. Han, R. Ram-
chandran, B. Thisse, C. Thisse, L.I. Zon, V.P. 
Sukhatme (2006) A novel endothelial-spe-
cific heat shock protein HspA12B is required 
in both zebrafish development and endothe-
lial functions in vitro. J Cell Sci  119: 4117–
4126.  
 Hynes, R.O. (2002) A reevaluation of integrins as 
regulators of angiogenesis. Nat Med  8: 918–
921.  
 Iruela-Arispe, M.L., G.E. Davis (2009) Cellular 
and molecular mechanisms of vascular lu-
men formation. Dev Cell  16: 222–231.  
 Isogai, S., N.D. Lawson, S. Torrealday, M. Hori-
guchi, B.M. Weinstein (2003) Angiogenic 
network formation in the developing verte-
brate trunk. Development  130: 5281–5290.  
 Jakobsson, L., A. Domogatskaya, K. Tryggvason, 
D. Edgar, L. Claesson-Welsh (2007a) Lam-
inin deposition is dispensable for vasculo-
genesis but regulates blood vessel diameter 
independent of f low. FASEB J  22: 1530–1539. 
 Jakobsson, L., C.A. Franco, K. Bentley, R.T. Col-
lins, B. Ponsioen, I.M. Aspalter, I. Rosewell, 
M. Busse, G. Thurston, A. Medvinsky, S. 
Schulte-Merker, H. Gerhardt (2010) Endo-
thelial cells dynamically compete for the tip 
cell position during angiogenic sprouting. 
Nat Cell Biol  12: 943–953.  
 Jakobsson, L., J. Kreuger, L. Claesson-Welsh 
(2007b) Building blood vessels – stem cell 
models in vascular biology. J Cell Biol  177: 
751–755.  
 Jakobsson, L., J. Kreuger, K. Holmborn, L. Lun-
din, I. Eriksson, L. Kjellen, L. Claesson-
Welsh (2006) Heparan sulfate in trans po-
tentiates VEGFR-mediated angiogenesis. 
Dev Cell  10: 625–634.  
 Jones, E.A., L. Yuan, C. Breant, R.J. Watts, A. 
Eichmann (2008) Separating genetic and he-
modynamic defects in neuropilin 1 knock-
out embryos. Development  135: 2479–2488. 
 Kamei, M., S. Isogai, W. Pan, B.M. Weinstein 
(2010) Imaging blood vessels in the zebra-
fish. Methods Cell Biol  100: 27–54.  
 Kamei, M., W.B. Saunders, K.J. Bayless, L. Dye, 
G.E. Davis, B.M. Weinstein (2006) Endothe-
lial tubes assemble from intracellular vacu-
oles in vivo. Nature  442: 453–456.  
 Kang, H., K.J. Bayless, R. Kaunas (2008) Fluid 
shear stress modulates endothelial cell inva-
sion into three-dimensional collagen matri-
ces. Am J Physiol Heart Circ Physiol  295: 
H2087–H2097.  
 Kappas, N.C., G. Zeng, J.C. Chappell, J.B. Kear-
ney, S. Hazarika, K.G. Kallianos, C. Patter-
son, B.H. Annex, V.L. Bautch (2008) The 
VEGF receptor Flt-1 spatially modulates Flk-
1 signaling and blood vessel branching. J Cell 
Biol  181: 847–858.  
 Kater, S.B., V. Rehder (1995) The sensory-motor 
role of growth cone filopodia. Curr Opin 
Neurobiol  5: 68–74.  
 Kearney, J.B., N.C. Kappas, C. Ellerstrom, F.W. 
DiPaola, V.L. Bautch (2004) The VEGF re-
ceptor flt-1 (VEGFR-1) is a positive modula-
tor of vascular sprout formation and branch-
ing morphogenesis. Blood  103: 4527–4535.  
 Kendall, R.L., K.A. Thomas (1993) Inhibition of 
vascular endothelial cell growth factor activ-
ity by an endogenously encoded soluble re-
ceptor. Proc Natl Acad Sci USA  90: 10705–
10709.  
 Koch, A.W., T. Mathivet, B. Larrivee, R.K. Tong, 
J. Kowalski, L. Pibouin-Fragner, K. Bouvree, 
S. Stawicki, K. Nicholes, N. Rathore, S.J. 
Scales, E. Luis, R. del Toro, C. Freitas, C. Bre-
ant, A. Michaud, P. Corvol, J.L. Thomas, Y. 
Wu, F. Peale, R.J. Watts, M. Tessier-Lavigne, 
A. Bagri, A. Eichmann (2011) Robo4 main-
tains vessel integrity and inhibits angiogen-
esis by interacting with UNC5B. Dev Cell  20: 
33–46.  
 Koh, W., A.N. Stratman, A. Sacharidou, G.E. Da-
vis (2008) In vitro three dimensional colla-
gen matrix models of endothelial lumen for-
mation during vasculogenesis and angiogen-
esis. Methods Enzymol  443: 83–101.  
 Krebs, L.T., C. Starling, A.V. Chervonsky, T. 
Gridley (2010) Notch1 activation in mice 
causes arteriovenous malformations pheno-
copied by ephrinB2 and EphB4 mutants. 
Genesis  48: 146–150.  
 Larina, I.V., W. Shen, O.G. Kelly, A.K. Hadjan-
tonakis, M.H. Baron, M.E. Dickinson (2009) 
A membrane associated mCherry fluores-
cent reporter line for studying vascular re-
modeling and cardiac function during mu-
rine embryonic development. Anat Rec 
(Hoboken)  292: 333–341.  
 Lawson, N.D., A.M. Vogel, B.M. Weinstein 
(2002) Sonic hedgehog and vascular endo-
thelial growth factor act upstream of the 
Notch pathway during arterial endothelial 
differentiation. Dev Cell  3: 127–136.  
 Lawson, N.D., B.M. Weinstein (2002) In vivo im-
aging of embryonic vascular development 
using transgenic zebrafish. Dev Biol  248: 
307–318.  
 Chappell  /Wiley  /Bautch  Cells Tissues Organs 2012;195:94–107106
 Lee, S., T.T. Chen, C.L. Barber, M.C. Jordan, J. 
Murdock, S. Desai, N. Ferrara, A. Nagy, K.P. 
Roos, M.L. Iruela-Arispe (2007) Autocrine 
VEGF signaling is required for vascular ho-
meostasis. Cell  130: 691–703.  
 Lee, S., S.M. Jilani, G.V. Nikolova, D. Carpizo, 
M.L. Iruela-Arispe (2005) Processing of 
VEGF-A by matrix metalloproteinases regu-
lates bioavailability and vascular patterning 
in tumors. J Cell Biol  169: 681–691.  
 Leslie, J.D., L. Ariza-McNaughton, A.L. Ber-
mange, R. McAdow, S.L. Johnson, J. Lewis 
(2007) Endothelial signalling by the Notch 
ligand Delta-like 4 restricts angiogenesis. 
Development  134: 839–844.  
 Leslie-Barbick, J.E., J.E. Saik, D.J. Gould, M.E. 
Dickinson, J.L. West (2011) The promotion 
of microvasculature formation in poly(eth-
ylene glycol) diacrylate hydrogels by an im-
mobilized VEGF-mimetic peptide. Biomate-
rials  32: 5782–5789.  
 Li, X., L. Claesson-Welsh, M. Shibuya (2008) 
VEGF receptor signal transduction. Meth-
ods Enzymol  443: 261–284.  
 Limbourg, F.P., K. Takeshita, F. Radtke, R.T. 
Bronson, M.T. Chin, J.K. Liao (2005) Essen-
tial role of endothelial Notch1 in angiogen-
esis. Circulation  111: 18261832.  
 Liu, H., B. Chen, B. Lilly (2008) Fibroblasts po-
tentiate blood vessel formation partially 
through secreted factor TIMP-1. Angiogen-
esis  11: 223–234.  
 Liu, Z.J., T. Shirakawa, Y. Li, A. Soma, M. Oka, 
G.P. Dotto, R.M. Fairman, O.C. Velazquez, 
M. Herlyn (2003) Regulation of Notch1 and 
Dll4 by vascular endothelial growth factor in 
arterial endothelial cells: implications for 
modulating arteriogenesis and angiogenesis. 
Mol Cell Biol  23: 14–25.  
 Lobov, I.B., R.A. Renard, N. Papadopoulos, N.W. 
Gale, G. Thurston, G.D. Yancopoulos, S.J. 
Wiegand (2007) Delta-like ligand 4 (Dll4) is 
induced by VEGF as a negative regulator of 
angiogenic sprouting. Proc Natl Acad Sci 
USA  104: 3219–3224.  
 Lu, X., F. Le Noble, L. Yuan, Q. Jiang, B. De La-
farge, D. Sugiyama, C. Breant, F. Claes, F. De 
Smet, J.L. Thomas, M. Autiero, P. Carmeliet, 
M. Tessier-Lavigne, A. Eichmann (2004) The 
netrin receptor UNC5B mediates guidance 
events controlling morphogenesis of the vas-
cular system. Nature  432 179–186.  
 Ma, A., R. Lin, P.K. Chan, J.C. Leung, L.Y. Chan, 
A. Meng, C.M. Verfaillie, R. Liang, A.Y. 
Leung (2007) The role of survivin in angio-
genesis during zebrafish embryonic develop-
ment. BMC Dev Biol  7: 50.  
 Mac Gabhann, F., A.S. Popel (2008) Systems bi-
ology of vascular endothelial growth factors. 
Microcirculation  15: 715–738.  
 Megason, S.G., S.E. Fraser (2003) Digitizing life 
at the level of the cell: high-performance la-
ser-scanning microscopy and image analysis 
for in toto imaging of development. Mech 
Dev  120: 1407–1420.  
 Merks, R.M., E.D. Perryn, A. Shirinifard, J.A. 
Glazier (2008) Contact-inhibited chemotax-
is in de novo and sprouting blood-vessel 
growth. PLoS Comput Biol  4: e1000163.  
 Morikawa, S., P. Baluk, T. Kaidoh, A. Haskell, 
R.K. Jain, D.M. McDonald (2002) Abnor-
malities in pericytes on blood vessels and en-
dothelial sprouts in tumors. Am J Pathol  160: 
985–1000.  
 Nakatsu, M.N., C.C. Hughes (2008) An opti-
mized three-dimensional in vitro model for 
the analysis of angiogenesis. Methods Enzy-
mol  443: 65–82.  
 Nehls, V., D. Drenckhahn (1995) A novel, micro-
carrier-based in vitro assay for rapid and re-
liable quantification of three-dimensional 
cell migration and angiogenesis. Microvasc 
Res  50: 311–322.  
 Nehls, V., E. Schuchardt, D. Drenckhahn (1994) 
The effect of fibroblasts, vascular smooth 
muscle cells, and pericytes on sprout forma-
tion of endothelial cells in a fibrin gel angio-
genesis system. Microvasc Res  48: 349–363.  
 Ng, Y.S., M. Ramsauer, R.M. Loureiro, P.A. 
D’Amore (2004) Identification of genes in-
volved in VEGF-mediated vascular morpho-
genesis using embryonic stem cell-derived 
cystic embryoid bodies. Lab Invest  84: 1209–
1218.  
 Nicoli, S., C. Standley, P. Walker, A. Hurlstone, 
K.E. Fogarty, N.D. Lawson (2010) MicroR-
NA-mediated integration of haemodynam-
ics and Vegf signalling during angiogenesis. 
Nature  464: 1196–1200.  
 Ocak, I., P. Baluk, T. Barrett, D.M. McDonald, P. 
Choyke (2007) The biologic basis of in vivo 
angiogenesis imaging. Front Biosci  12: 3601–
3616.  
 Patel, N.S., J.L. Li, D. Generali, R. Poulsom, D.W. 
Cranston, A.L. Harris (2005) Upregulation 
of delta-like 4 ligand in human tumor vascu-
lature and the role of basal expression in en-
dothelial cell function. Cancer Res  65: 8690–
8697.  
 Peirce, S.M. (2008) Computational and mathe-
matical modeling of angiogenesis. Microcir-
culation  15: 739–751.  
 Perryn, E.D., A. Czirok, C.D. Little (2008) Vas-
cular sprout formation entails tissue defor-
mations and VE-cadherin-dependent cell-
autonomous motility. Dev Biol  313: 545–555. 
 Phng, L.K., H. Gerhardt (2009) Angiogenesis: a 
team effort coordinated by notch. Dev Cell 
 16: 196–208.  
 Phng, L.K., M. Potente, J.D. Leslie, J. Babbage, D. 
Nyqvist, I. Lobov, J.K. Ondr, S. Rao, R.A. 
Lang, G. Thurston, H. Gerhardt (2009) 
Nrarp coordinates endothelial Notch and 
Wnt signaling to control vessel density in an-
giogenesis. Dev Cell  16: 70–82.  
 Pitulescu, M.E., I. Schmidt, R. Benedito, R.H. 
Adams (2010) Inducible gene targeting in the 
neonatal vasculature and analysis of retinal 
angiogenesis in mice. Nat Protoc  5: 1518–
1534.  
 Ribeiro, C., A. Ebner, M. Affolter (2002) In vivo 
imaging reveals different cellular functions 
for FGF and Dpp signaling in tracheal 
branching morphogenesis. Dev Cell  2: 677–
683.  
 Ridgway, J., G. Zhang, Y. Wu, S. Stawicki, W.C. 
Liang, Y. Chanthery, J. Kowalski, R.J. Watts, 
C. Callahan, I. Kasman, M. Singh, M. Chien, 
C. Tan, J.A. Hongo, F. de Sauvage, G. Plow-
man, M. Yan (2006) Inhibition of Dll4 sig-
nalling inhibits tumour growth by deregu-
lating angiogenesis. Nature  444: 1083–1087. 
 Risau, W. (1997) Mechanisms of angiogenesis. 
Nature  386: 671–674.  
 Risau, W., H. Sariola, H.G. Zerwes, J. Sasse, P. 
Ekblom, R. Kemler, T. Doetschman (1988) 
Vasculogenesis and angiogenesis in embry-
onic-stem-cell-derived embryoid bodies. 
Development  102: 471–478.  
 Roberts, D.M., J.B. Kearney, J.H. Johnson, M.P. 
Rosenberg, R. Kumar, V.L. Bautch (2004) 
The vascular endothelial growth factor 
(VEGF) receptor Flt-1 (VEGFR-1) modulates 
Flk-1 (VEGFR-2) signaling during blood 
vessel formation. Am J Pathol  164: 1531–
1535.  
 Roca, C., R.H. Adams (2007) Regulation of vas-
cular morphogenesis by Notch signaling. 
Genes Dev  21: 2511–2524.  
 Ruhrberg, C., H. Gerhardt, M. Golding, R. Wat-
son, S. Ioannidou, H. Fujisawa, C. Betsholtz, 
D.T. Shima (2002) Spatially restricted pat-
terning cues provided by heparin-binding 
VEGF-A control blood vessel branching 
morphogenesis. Genes Dev  16: 2684–2698.  
 Sainson, R.C., J. Aoto, M.N. Nakatsu, M. Hold-
erfield, E. Conn, E. Koller, C.C. Hughes 
(2005) Cell-autonomous notch signaling 
regulates endothelial cell branching and pro-
liferation during vascular tubulogenesis. 
FASEB J  19: 1027–1029.  
 Sawamiphak, S., M. Ritter, A. Acker-Palmer 
(2010a) Preparation of retinal explant cul-
tures to study ex vivo tip endothelial cell re-
sponses. Nat Protoc  5: 1659–1665.  
 Sawamiphak, S., S. Seidel, C.L. Essmann, G.A. 
Wilkinson, M.E. Pitulescu, T. Acker, A.
Acker-Palmer (2010b) Ephrin-B2 regulates 
VEGFR2 function in developmental and tu-
mour angiogenesis. Nature  465: 487–491.  
 Shawber, C.J., Y. Funahashi, E. Francisco, M. Vo-
rontchikhina, Y. Kitamura, S.A. Stowell, V. 
Borisenko, N. Feirt, S. Podgrabinska, K. Shi-
raishi, K. Chawengsaksophak, J. Rossant, D. 
Accili, M. Skobe, J. Kitajewski (2007) Notch 
alters VEGF responsiveness in human and 
murine endothelial cells by direct regulation 
of VEGFR-3 expression. J Clin Invest  117: 
3369–3382.  
 Siekmann, A.F., L. Covassin, N.D. Lawson 
(2008) Modulation of VEGF signalling out-
put by the Notch pathway. Bioessays  30: 303–
313.  
 Siekmann, A.F., N.D. Lawson (2007) Notch sig-
nalling limits angiogenic cell behaviour in 
developing zebrafish arteries. Nature  445: 
781–784.  
 Blood Vessel Sprouting Cells Tissues Organs 2012;195:94–107 107
 Stalmans, I., Y.S. Ng, R. Rohan, M. Fruttiger, A. 
Bouche, A. Yuce, H. Fujisawa, B. Hermans, 
M. Shani, S. Jansen, D. Hicklin, D.J. Ander-
son, T. Gardiner, H.P. Hammes, L. Moons, 
M. Dewerchin, D. Collen, P. Carmeliet, P.A. 
D’Amore (2002) Arteriolar and venular pat-
terning in retinas of mice selectively express-
ing VEGF isoforms. J Clin Invest  109: 327–
336.  
 Strasser, G.A., J.S. Kaminker, M. Tessier-Lavigne 
(2010) Microarray analysis of retinal endo-
thelial tip cells identifies CXCR4 as a media-
tor of tip cell morphology and branching. 
Blood  115: 5102–5110.  
 Stratman, A.N., K.M. Malotte, R.D. Mahan, M.J. 
Davis, G.E. Davis (2009) Pericyte recruit-
ment during vasculogenic tube assembly 
stimulates endothelial basement membrane 
matrix formation. Blood  114: 5091–5101.  
 Strilic, B., J. Eglinger, M. Krieg, M. Zeeb, J. 
Axnick, P. Babal, D.J. Muller, E. Lammert 
(2010) Electrostatic cell-surface repulsion 
initiates lumen formation in developing 
blood vessels. Curr Biol  20: 2003–2009.  
 Strilic, B., T. Kucera, J. Eglinger, M.R. Hughes, 
K.M. McNagny, S. Tsukita, E. Dejana, N. 
Ferrara, E. Lammert (2009) The molecular 
basis of vascular lumen formation in the de-
veloping mouse aorta. Dev Cell  17: 505–515. 
 Suchting, S., C. Freitas, F. le Noble, R. Benedito, 
C. Breant, A. Duarte, A. Eichmann (2007) 
The Notch ligand Delta-like 4 negatively reg-
ulates endothelial tip cell formation and ves-
sel branching. Proc Natl Acad Sci USA  104: 
3225–3230.  
 Tammela, T., G. Zarkada, E. Wallgard, A. Mur-
tomaki, S. Suchting, M. Wirzenius, M. Wal-
tari, M. Hellstrom, T. Schomber, R. Peltonen, 
C. Freitas, A. Duarte, H. Isoniemi, P. Laak-
konen, G. Christofori, S. Yla-Herttuala,
M. Shibuya, B. Pytowski, A. Eichmann,
C. Betsholtz, K. Alitalo (2008) Blocking
VEGFR-3 suppresses angiogenic sprouting 
and vascular network formation. Nature 
 454: 656–660.  
 Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. 
Gospodarowicz, J.C. Fiddes, J.A. Abraham 
(1991) The human gene for vascular endo-
thelial growth factor: multiple protein forms 
are encoded through alternative exon splic-
ing. J Biol Chem  266: 11947–11954.  
 Tran, T.C., B. Sneed, J. Haider, D. Blavo, A. 
White, T. Aiyejorun, T.C. Baranowski, A.L. 
Rubinstein, T.N. Doan, R. Dingledine, E.M. 
Sandberg (2007) Automated, quantitative 
screening assay for antiangiogenic com-
pounds using transgenic zebrafish. Cancer 
Res  67: 11386–11392.  
 Vempati, P., F. Mac Gabhann, A.S. Popel (2010) 
Quantifying the proteolytic release of extra-
cellular matrix-sequestered VEGF with a 
computational model. PLoS One  5: e11860.  
 Vickerman, M.B., P.A. Keith, T.L. McKay, D.J. 
Gedeon, M. Watanabe, M. Montano, G. Ka-
runamuni, P.K. Kaiser, J.E. Sears, Q. Ebra-
hem, D. Ribita, A.G. Hylton, P. Parsons-
Wingerter (2009) VESGEN 2D: automated, 
user-interactive software for quantification 
and mapping of angiogenic and lymphangi-
ogenic trees and networks. Anat Rec (Hobo-
ken)  292: 320–332.  
 Vickerman, V., J. Blundo, S. Chung, R. Kamm 
(2008) Design, fabrication and implementa-
tion of a novel multi-parameter control mi-
crofluidic platform for three-dimensional 
cell culture and real-time imaging. Lab Chip 
 8: 1468–1477.  
 Wang, R., R. Clark, V.L. Bautch (1992) Embry-
onic stem cell-derived cystic embryoid bod-
ies form vascular channels: an in vitro mod-
el of blood vessel development. Development 
 114: 303–316.  
 Wiley, D.M., J. Kim, J. Hao, C.C. Hong, V.L. 
Bautch, S.W. Jin (2011) Distinct signaling 
pathways regulate sprouting angiogenesis 
from the dorsal aorta and axial vein. Nat Cell 
Biol  13: 686–692.  
 Williams, C.K., J.L. Li, M. Murga, A.L. Harris, 
G. Tosato (2006) Up-regulation of the Notch 
ligand Delta-like 4 inhibits VEGF-induced 
endothelial cell function. Blood  107: 931–
939.  
 Winderlich, M., L. Keller, G. Cagna, A. Broer-
mann, O. Kamenyeva, F. Kiefer, U. Deutsch, 
A.F. Nottebaum, D. Vestweber (2009)
VE-PTP controls blood vessel development 
by balancing Tie-2 activity. J Cell Biol  185: 
657–671.  
 You, W.K., B. Sennino, C.W. Williamson, B. Fal-
con, H. Hashizume, L.C. Yao, D.T. Aftab, 
D.M. McDonald (2011) VEGF and c-Met 
blockade amplify angiogenesis inhibition in 
pancreatic islet cancer. Cancer Res  71: 4758–
4768.  
 Zeng, G., V.L. Bautch (2009) Differentiation and 
dynamic analysis of primitive vessels from 
embryonic stem cells. Methods Mol Biol  482: 
333–344. 
 
